Gurevich, K.G.,
Urakov, A.L.,
Khaliullin, F.A.,
Samorodov, A.V.,
Shabalina, Y.V.,
Kamilov, F.K.,
Murataev, D.Z.,
Bashirova, L.I. (2020) were confirmed using IR and PMR spectroscopy. The synthesized compounds exhibited
anti-aggregationGUREVICH, K.G.,
URAKOV, A.L.,
KHALIULLIN, F.A.,
SAMORODOV, A.V.,
SHABALINA, Y.V.,
KAMILOV, F.KH.,
MURATAEV, D.Z.,
BASHIROVA, L.I. (2020) were confirmed using IR and PMR spectroscopy. The synthesized compounds exhibited
anti-aggregationGurevich, KG,
Urakov, AL,
Basantsev, AV,
Abzalilov, TA,
Bashirov, II,
Danilin, AA,
Purygin, PP,
Golovanov, AA,
Khayrzamanova, KA,
Samorodov, AV (2021) structures with various types of biological activity, e.g.,
antiaggregant and anticoagulant. The present work
Faizullina, L. Kh.,
Karamisheva, L. Sh.,
Yakupova, L. R.,
Migranov, A. R.,
Saifullin, R. L.,
Valeev, F. A.,
Valiullina, Z. A.,
Samorodov, A. V. (2024) synthesized in one step. The antioxidant, anticoagulation, and
antiaggregation activities of the obtained
synthesized by reaction of III with organic and inorganic bases. Compounds possessing
antiaggregant activity
Liu, Kang,
Wong, Chris Ho-Ming,
Zhao, Hongda,
Ng, Chi Fai,
Teoh, Jeremy Yuen-Chun,
Laguna, Pilar (2025) .66). Conclusions and clinical implications: Anticoagulant and
antiaggregant therapy in patients undergoing RNU
URAKOV, A.L.,
MUSTAFIN, I.G.,
NABIULLINA, R.M.,
BASHIROVA, L.I.,
MOCHALOV, K.S.,
SAMORODOV, A.V.,
KHALIULLIN, F.A.,
LIPATOV, D.O.,
KORUNAS, V.I.,
KHALIMOV, A.R. (2020) . The effect of
anti-aggregants was characterized by a significant decrease in МА. The potential of TEG as a